Skip to main content
. 2015 May 20;5:10405. doi: 10.1038/srep10405

Figure 5. Antagonist-mediated expression of CYP2B6 and CYP3A4 in HPH.

Figure 5

HPH were treated with the vehicle control (0.1% DMSO) or each of the 10 potential antagonists selected from the qHTS at indicated concentrations for 24 h. Real-time PCR was used to analyze the expression of CYP2B6 (A) and CYP3A4 (B), respectively. Data represents the mean±SD (n = 3). *, P < 0.05; **, P < 0.01; ***, P < 0.001.